fexofenadine: Clinical Trials

81 trials of fexofenadine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

63 completed, 7 recruiting, 5 unknown, 4 terminated. 27 Phase 4, 24 Phase 1, 13 Phase 2, 13 Phase 3, 6 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 427Completed 24, Unknown 2, Terminated 1
Phase 124Completed 19, Recruiting 2, Terminated 2, Unknown 1
Phase 213Completed 8, Recruiting 3, Not yet recruiting 1, Terminated 1
Phase 313Completed 9, Recruiting 3, Active not recruiting 1
Not applicable6Completed 4, Recruiting 1, Unknown 1
Early Phase 11Completed 1

Follow fexofenadine: new trials by email Literature Review of fexofenadine trials Research Report on fexofenadine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mast Cell Treatment in Post-tick Bite Illness (PTBI)
Ketotifen, fexofenadine, Cromolyn Sodium - Tick Bites, Mast Cell Activation Disorders
Phase 2Not yet recruitingUniversity of North Carolina, Chapel Hill502027-01-012026-11-09
A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin
KarXT, Midazolam, Fexofenadine - Healthy Volunteers
Phase 1CompletedKaruna Therapeutics, Inc., a Bristol Myers Squibb company622025-09-292026-07-22
Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above
Fexofenadine HCL and pseudoephedrine HCL - Rhinitis Allergic
Phase 4CompletedSanofi2032025-06-152026-02-17
Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment
Experimental drug (paracetamol 500mg / fexofenadine 60mg / phenylephrine 20mg), Placebo - Cold, Flu Symptom
Phase 3CompletedEurofarma Laboratorios S.A.5672025-03-262026-10-26
The Impact of Fexofenadine Hydrochloride on the Prognosis of Patients Post-Acute Myocardial Infarction
Fexofenadine 60 Mg Oral Tablet, Placebo - Zhejiang University
Phase 3RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine28042025-01-272026-08-07
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
Fexofenadine Hydrochloride, Placebo - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1602025-01-202026-09-16
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Levodopa/carbidopa, Fexofenadine - Parkinson Disease
Phase 2 / Phase 3RecruitingTanta University462024-12-102026-01-21
Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus
Phase 4CompletedTanta University602024-07-012025-04-27
Effect of Aerobic Exercise with Blood Flow Restriction on Post-exercise Hypotension in Young Adults: the Role of Histamine Receptors
H1 receptor blockade: 540 mg (Allegra), H2 receptor blockade: 40 mg (Pepcid AC) - Prehypertension (elevated Blood Pressure) or Hypertension
Not applicableCompletedCalifornia Baptist University102024-04-012024-10-08
Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers
AV078, Placebo, Itraconazole - Healthy Participants
Phase 1CompletedAeovian Pharmaceuticals, Inc.892024-01-312025-03-26
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
AGALSIDASE BETA (GZ419828), Acetaminophen, Diphenhydramine - Fabry's Disease
Phase 4CompletedSanofi82023-11-102025-10-21
The Role of Histamine in Muscle Protein Synthesis Following Resistance Training
Placebo, H1 blockade: Telfast: 180mg Fexofenadine, Resistance training - Histamine
Not applicableRecruitingUniversity Ghent502023-09-012023-12-13
A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
BMS-986419, Caffeine, Bupropion - Healthy Volunteers
Phase 1CompletedBristol-Myers Squibb222023-06-292023-10-30
Excipient Effect on Drug Absorption in Humans
Fexofenadine Hydrochloride without sodium lauryl sulfate, Fexofenadine Hydrochloride with sodium lauryl sulfate - The Impact of Excipients on Drug Absorption
Early Phase 1CompletedUniversity of California, San Francisco122023-01-312025-11-18
A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Fexofenadine, Placebo - Seasonal Allergic Rhinitis
Phase 3CompletedOpella Healthcare Group SAS, a Sanofi Company952023-01-232025-09-09
Fexofenadine in Patients With Active Rheumatoid Arthritis
Fexofenadine, Placebo - Rheumatoid Arthritis
Phase 1 / Phase 2RecruitingOctober 6 University802022-06-012025-07-31
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Dupilumab, Placebo, Fexofenadine (loratadine if not available) - Pruritus
Phase 3RecruitingSanofi2842022-02-152026-10-15
Role of Antihistaminic in Acute Renal Colic Prevent Pain Recurrence and Expulsion of Ureteric Stone ≤ 1cm
Tamsulosin Hcl 0.4Mg Cap, fexofenadine 180 mg Oral tablet - Renal Colic, Ureter Stone
UnknownAssiut University1002021-11-302021-12-09
Effect of Antihistamines on Ureteral Stent-Related Symptoms
Fexofenadine Hcl 180Mg Tab, Placebo - Nephrolithiasis
Phase 2CompletedColumbia University782021-06-292025-07-16
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
Rituximab, Ocrelizumab, Fexofenadine - Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
Phase 3Active not recruitingCopenhagen University Hospital, Rigshospitalet6002021-04-282026-08-17

Showing 20 of 81. Sign in to see all of them.

Conditions studied

Rhinitis, Allergic, Seasonal (11)  ·  Rhinitis, Allergic (9)  ·  Pruritus (4)  ·  Asthma (3)  ·  Rhinitis, Allergic, Perennial (3)  ·  Hypertension (2)  ·  Rhinitis (2)  ·  Arthritis, Rheumatoid (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Chronic Urticaria (1)  ·  Common Cold (1)  ·  Depression (1)  ·  Dermatitis, Atopic (1)  ·  Diabetic Nephropathies (1)  ·  Edema (1)

Sponsors

Sanofi (17)  ·  Dr. Reddy's Laboratories Limited (5)  ·  Organon and Co (5)  ·  Pfizer (3)  ·  Tanta University (3)  ·  GlaxoSmithKline (2)  ·  Jules Desmeules (2)  ·  Mylan Pharmaceuticals Inc (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Teva Pharmaceuticals USA (2)  ·  University Ghent (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Aeovian Pharmaceuticals, Inc. (1)  ·  Alexion Pharmaceuticals, Inc. (1)  ·  Amgen (1)

Countries

United States (29)  ·  Canada (6)  ·  Japan (5)  ·  Egypt (4)  ·  India (4)  ·  South Korea (4)  ·  China (3)  ·  France (3)  ·  Hungary (3)  ·  Poland (3)  ·  Switzerland (3)  ·  Belgium (2)  ·  Costa Rica (2)  ·  Germany (2)  ·  Guatemala (2)

Top investigators

Phyllis Diener (6)  ·  Dr. Dharmesh Domadia (2)  ·  James D Carlson, Pharm. D. (2)  ·  Thomas S Clark, M.D. (2)  ·  Ahmed M Hussein, PhD (1)  ·  Benoit Girard, M.D (1)  ·  Carmela Pagunsan (1)  ·  Celia Lloret-Linares, MD, PhD (1)  ·  Dal-Sik Kim, PhD, MD (1)  ·  Daniele Santini, MD, PhD (1)

Results publications

PMID 11756098, PMID 12072644, PMID 16913264, PMID 17011944, PMID 17102958, PMID 19943178, PMID 22266271, PMID 22995650, PMID 23018163, PMID 23147964, PMID 24018772, PMID 2466358, PMID 24722393, PMID 25024716, PMID 25530364, PMID 27326985, PMID 27495955, PMID 27746690, PMID 27908918, PMID 28709817, PMID 29570971, PMID 30875094, PMID 33283264, PMID 36099211, PMID 37741921, PMID 38447697, PMID 39678124, PMID 39937815, PMID 42775939

NIH funding

2018 (1), 2023 (1)